| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 03/05/2009 | US20090062318 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| 03/05/2009 | US20090062317 Medicinal use of receptor ligands |
| 03/05/2009 | US20090062282 Substituted Amino-Pyrimidones and Uses Thereof |
| 03/05/2009 | US20090062258 Fused pyrimidine derivative and use thereof |
| 03/05/2009 | US20090062125 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
| 03/05/2009 | US20090060968 Inhibitors of phosphatases |
| 03/05/2009 | US20090060912 Small molecule pi 3-kinase inhibitors and methods of their use |
| 03/05/2009 | CA2698018A1 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof |
| 03/05/2009 | CA2697946A1 New bradykinin b1-antagonists |
| 03/05/2009 | CA2695644A1 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
| 03/04/2009 | EP2030621A1 Novel substituted pyrimidines as cysteine protease inhibitors |
| 03/04/2009 | EP2029552A1 Sulfimides as protein kinase inhibitors |
| 03/04/2009 | EP1551812B1 Mitotic kinesin inhibitors |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1427720B1 3-substituted-4-pyrimidone derivatives |
| 03/04/2009 | CN101379043A Substituted 2-Aminopyrimidine-4-ones, their pharmaceutical compositions and their use in the treatment and/or prevention of ass-related pathologies |
| 03/04/2009 | CN101379022A Benzamide and heteroarene derivatives |
| 03/04/2009 | CN101376647A Method for synthesizing rosuvastatin intermediate and rosuvastatin |
| 03/04/2009 | CN101376637A High cubane diamide compound and use thereof |
| 03/04/2009 | CN100465164C A selective synthesis of CF3-substituted pyrimidines |
| 03/03/2009 | US7498436 Substituted hydroxyethylamines |
| 03/03/2009 | US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine |
| 03/03/2009 | US7498336 anticancer agents; to regulate p53 and MDM2 stability and activity; 10-(3-chloro-phenyl)-7-nitro-10H-pyrimido[4,5-b]quinoline-2,4-dione, and 10-(4-chloro-phenyl)-7-nitro-10H-pyrimido[4,5-b]quinoline-2,4-dione |
| 03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 03/03/2009 | CA2237368C 5'-deoxy-cytidine derivatives |
| 02/26/2009 | WO2009026326A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | WO2009026319A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | WO2009026276A1 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 02/26/2009 | WO2009025876A2 Crystalline forms of erlotinib hcl and formulations thereof |
| 02/26/2009 | WO2009025875A1 Stable formulations of crystalline erlotinib hcl |
| 02/26/2009 | WO2009025873A2 Processes for the preparation of crystalline forms a, b and pure crystalline form a of erlotinib hcl |
| 02/26/2009 | WO2009025397A1 Fluorine-containing organosulfur compound and pesticidal composition thereof |
| 02/26/2009 | WO2009025239A1 Novel preparation for external use |
| 02/26/2009 | WO2009025238A1 Method for producing quinazoline derivative |
| 02/26/2009 | WO2009024989A2 A novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b |
| 02/26/2009 | WO2009024492A1 Leukotriene b4 inhibitors |
| 02/26/2009 | WO2009024323A2 Process for preparing pyrimidine derivatives |
| 02/26/2009 | WO2009024251A2 Use of sulfonanilide compounds as herbicide |
| 02/26/2009 | WO2009004653A3 Process for preparing an amorphous form of (2s,3s,5s)-2-(2,6- dimethylphenoxyacetyl)-amino-3-hydroxy-5-(2-(1-tetrahydropyrimid-2-only)-3-methylbutanoyl)-amino-1,6-diphenyl hexane and product thereof |
| 02/26/2009 | WO2008140553A3 Mapk/erk kinase inhibitors |
| 02/26/2009 | WO2008093205A3 A method for the purification of rosuvastatin intermediate |
| 02/26/2009 | WO2008024439A3 4-aminoquinazoline derivatives and methods of use thereof |
| 02/26/2009 | US20090054647 Method for Preparing Substituted Pyrimidines |
| 02/26/2009 | US20090054646 Method for Production of Quinazolin 4-One Derivative |
| 02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
| 02/26/2009 | US20090054469 Quinazolinone derivatives and their use as b-raf inhibitors |
| 02/26/2009 | US20090054436 anticarcinogenic compounds; ; N-(4-(2-Aminopyridin-4-yloxy)-3-fluorophenyl)-2-bromoisonicotinamide, trifluoroacetic acid salt; inhibit the protein tyrosine kinase activity of growth factor receptors like Hepatocyte growth factor |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054409 [4-(4-imidazo[1,2-a]pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-morpholin-4-yl-methanone, used for treating rheumatoid arthritis in mammals |
| 02/26/2009 | US20090054395 focal adhesion kinase inhibitor, i.e. FAK inhibitor; tyrosine kinase inhibitors; cancer, osteoporosis; e.g. N-methyl-4-({4-[({3-[methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride |
| 02/26/2009 | US20090054392 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | CA2697100A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | CA2697081A1 5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 02/26/2009 | CA2696967A1 Leukotriene b4 inhibitors |
| 02/26/2009 | CA2696793A1 Novel preparation for external use |
| 02/26/2009 | CA2696727A1 Method for producing quinazoline derivative |
| 02/26/2009 | CA2696195A1 Process for preparing pyrimidine derivatives |
| 02/25/2009 | CN101374819A Aryl-substituted quinazolones and uses thereof |
| 02/25/2009 | CN101374818A Pyrimidine derivatives |
| 02/25/2009 | CN101374817A Trisubstituted amine compound as inhibitors of cholesteryl ester transfer protein cetp |
| 02/25/2009 | CN101374813A Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders |
| 02/25/2009 | CN101372475A Aromatic heterocyclic substituted acardite derivative and use thereof |
| 02/24/2009 | US7495104 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 02/24/2009 | US7495096 Processes for the production of chinazoline alkaloids |
| 02/24/2009 | US7495006 reverse transcriptase (polymerase) inhibitor; viricide, antiproliferative agent; Retroviridae (including HIV), Hepadnaviridae (including HBV), or Flaviviridae (including BVDV and HCV) infection, AIDS |
| 02/24/2009 | US7495001 Benzannelated derivatives, their manufacture and use as pharmaceutical agents |
| 02/24/2009 | US7495000 Variolin derivatives and their use as antitumor agents |
| 02/24/2009 | US7494997 excellent BCR-ABL tyrosine kinase inhibitory activity; to treat leukemias; 3-bromo-4-(4-methylpiperazin-1-ylmethyl)-N-{4-methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]phenyl}benzamide; compounds with cell growth inhibitory effect |
| 02/24/2009 | US7494989 Pyridine compounds useful as N-type calcium channel antagonists |
| 02/19/2009 | WO2009023438A1 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides |
| 02/19/2009 | WO2009022722A1 Tricyclic amine compound |
| 02/19/2009 | WO2009021696A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | US20090048442 Novel compounds |
| 02/19/2009 | US20090048280 such as 2-Amino-3-(4-(2-amino-6-((R)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid, used as tryptophan hydroxylase inhibitors |
| 02/19/2009 | US20090048279 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 02/19/2009 | US20090048278 Novel Quinazoline-2,4-Diamine Derivatives and Their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels |
| 02/19/2009 | US20090048272 Preparation of paliperidone |
| 02/19/2009 | US20090048265 Novel antitumor agents and methods of their use |
| 02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 02/19/2009 | US20090048230 Compounds and compositions useful as cathepsin s inhibitors |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048201 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 02/19/2009 | US20090048109 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides |
| 02/19/2009 | CA2695984A1 Tricyclic amine compound |
| 02/19/2009 | CA2695475A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | CA2694963A1 2-(2-fluoro-substituted phenyl)-6-amino-5-chloro-4-pyrimidinecarboxylates and their use as herbicides |
| 02/19/2009 | CA2681267A1 Anti-angiogenic agents and methods of use |
| 02/18/2009 | EP2025665A1 Process for producing substituted aniline compound |
| 02/18/2009 | EP2024342A2 Substituted 2-amino-fused heterocyclic compounds |
| 02/18/2009 | EP2024341A2 Novel process for statins and its pharmaceutically acceptable salts thereof |
| 02/18/2009 | EP2024340A1 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments |
| 02/18/2009 | EP2024339A1 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments |
| 02/18/2009 | EP2024338A1 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments |
| 02/18/2009 | EP2024333A2 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 02/18/2009 | EP1603886B1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors |
| 02/18/2009 | EP1569914B1 Pyrimidine-sulfamides and their use as endothelian receptor antagonist |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1361246B1 Organic polymer and novel polymerizable compound |
| 02/18/2009 | CN101370792A Bi-aryl meta-pyrimidine inhibitors of kinases |